OSE has signed a strategic partnership with Scienta Lab, aiming to model inflammatory diseases and identify predictive biomarkers of efficacy for immunotherapies. Scienta Lab is a France-based leader in AI-driven precision immunology, and under this agreement, it will be employing its AI-powered multimodal foundation model dedicated to translational immunology research. Ultimately, OSE believes this partnership will support the development of tailored immunotherapies and drive more favourable outcomes for patients with immune-mediated inflammatory conditions.
TMT | Comment
Industrials | Comment
Industrials | Comment